These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 27835582
1. Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer. Wu S, Zhao X, Wu S, Du R, Zhu Q, Fang H, Zhang X, Zhang C, Zheng W, Yang J, Feng H. Oncotarget; 2016 Dec 06; 7(49):81750-81756. PubMed ID: 27835582 [Abstract] [Full Text] [Related]
2. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis. Tan Z, Shen W. Oncotarget; 2017 Apr 18; 8(16):27137-27144. PubMed ID: 28404927 [Abstract] [Full Text] [Related]
3. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer. Jin Y, Zhang P, Li J, Zhao J, Liu C, Yang F, Yang D, Gao A, Lin W, Ma X, Sun Y. Int J Clin Exp Pathol; 2015 Apr 18; 8(11):13987-95. PubMed ID: 26823710 [Abstract] [Full Text] [Related]
5. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis. Zhao S, Qiu Z, He J, Li L, Li W. Int J Clin Exp Pathol; 2014 Apr 18; 7(10):6694-704. PubMed ID: 25400749 [Abstract] [Full Text] [Related]
8. Upregulation of soluble B7-H3 in NSCLC-derived malignant pleural effusion: A potential diagnostic biomarker correlated with NSCLC staging. Chen L, Zhang G, Sheng S, Zhou Q, Pan Y, Guan S. Clin Chim Acta; 2016 Jun 01; 457():81-5. PubMed ID: 27071700 [Abstract] [Full Text] [Related]
10. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis. Zhang J, Gu Y, Liu X, Rao X, Huang G, Ouyang Y. Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 32696952 [Abstract] [Full Text] [Related]
11. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer. Yim J, Koh J, Kim S, Song SG, Ahn HK, Kim YA, Jeon YK, Chung DH. Eur J Cancer; 2020 Jul 31; 133():74-85. PubMed ID: 32447027 [Abstract] [Full Text] [Related]
12. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis. Min SH, Zheng QQ. Medicine (Baltimore); 2021 Nov 24; 100(47):e27919. PubMed ID: 34964763 [Abstract] [Full Text] [Related]
13. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis. Zhang B, Xie Z, Li B. Gene; 2019 Mar 20; 689():76-83. PubMed ID: 30552981 [Abstract] [Full Text] [Related]
16. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review. Luo Z, Wu RR, Lv L, Li P, Zhang LY, Hao QL, Li W. Int J Clin Exp Pathol; 2014 Mar 20; 7(7):3632-46. PubMed ID: 25120740 [Abstract] [Full Text] [Related]
18. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis. Xuan ZX, Zhang S, Yuan SJ, Wang W, Yu J. World J Surg Oncol; 2016 Sep 02; 14(1):237. PubMed ID: 27589869 [Abstract] [Full Text] [Related]